Mamoru Ohkita Selected Research

Mamoru Ohkita Research Topics

Disease

28	Ischemia 01/2019 - 04/2005
21	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 03/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2007
7	Hypertension (High Blood Pressure) 01/2020 - 05/2005
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 09/2008
5	Pulmonary Hypertension 01/2021 - 07/2009
5	Reperfusion Injury 07/2013 - 08/2002
4	Vascular Diseases (Vascular Disease) 11/2014 - 04/2005
4	Necrosis 09/2005 - 08/2002
3	Chronic Renal Insufficiency 01/2022 - 01/2009
3	Right Ventricular Hypertrophy 01/2021 - 06/2018
3	Metrorrhagia (Spotting) 02/2011 - 04/2007
2	Hyperplasia 08/2019 - 12/2009
2	Vascular Remodeling 01/2019 - 10/2012
2	Proteinuria 01/2014 - 05/2008
2	Wounds and Injuries (Trauma) 10/2012 - 07/2005
2	Atherosclerosis 01/2012 - 01/2012
2	Neointima 02/2011 - 12/2009
2	Ventricular Remodeling 07/2009 - 05/2005
1	Renovascular Hypertension (Goldblatt Syndrome) 01/2022
1	Vascular Ring 01/2021
1	Fistula 08/2019
1	Disease Progression 06/2018
1	Vascular System Injuries 11/2014
1	Hypertrophy 01/2012
1	Inflammation (Inflammations) 01/2011

Drug/Important Bio-Agent (IBA)

20	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 04/2005
12	Endothelin-1 (Endothelin 1)IBA 01/2012 - 08/2002
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 08/2002
9	Endothelins (Endothelin)IBA 11/2014 - 06/2006
7	SaltsIBA 01/2020 - 05/2005
6	Superoxides (Superoxide)IBA 08/2019 - 12/2006
5	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2020 - 12/2006
4	Nitric Oxide Synthase (NO Synthase)IBA 01/2020 - 07/2005
4	AtrasentanIBA 07/2012 - 04/2007
3	Soluble Guanylyl CyclaseIBA 01/2022 - 01/2009
3	MonocrotalineIBA 01/2021 - 07/2009
3	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2020 - 12/2006
3	Acetates (Acetic Acid Esters)FDA Link 01/2020 - 12/2006
3	Malondialdehyde (Propanedial)IBA 01/2019 - 12/2011
3	Estrogens (Estrogen)FDA Link 11/2014 - 09/2012
3	Endothelin-Converting EnzymesIBA 05/2011 - 09/2008
3	Carboxylic AcidsIBA 02/2011 - 09/2008
3	flavangenolIBA 01/2011 - 09/2005
2	IndicanIBA 01/2022 - 01/2021
2	NitratesIBA 01/2021 - 01/2019
2	Thioctic Acid (Lipoic Acid)IBA 08/2019 - 03/2002
2	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2019 - 12/2006
2	Messenger RNA (mRNA)IBA 08/2019 - 08/2002
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2019 - 12/2011
2	2- amino- 4- ((3- (carboxymethyl)phenyl)(methyl)phosphono)butanoic acidIBA 01/2019 - 12/2011
2	Angiotensin Receptor AntagonistsIBA 11/2014 - 05/2005
2	moxonidine (Moxon)IBA 10/2013 - 01/2009
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2013 - 05/2008
2	tempolIBA 07/2013 - 04/2005
2	Pharmaceutical PreparationsIBA 01/2013 - 01/2009
2	Estrogen ReceptorsIBA 01/2013 - 05/2012
2	candesartanIBA 07/2012 - 05/2005
2	gamma-Aminobutyric Acid (GABA)IBA 09/2011 - 11/2009
2	GABA-B Receptor AntagonistsIBA 09/2011 - 11/2009
2	GABA-B ReceptorsIBA 09/2011 - 11/2009
2	benzocycloheptapyridineIBA 02/2011 - 12/2009
2	AcidsIBA 02/2011 - 12/2009
2	J 104132IBA 02/2011 - 12/2009
2	AntioxidantsIBA 01/2011 - 03/2002
2	NF-kappa B (NF-kB)IBA 09/2007 - 04/2005
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2021
1	neutrophil cytosol factor 67KIBA 08/2019
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 08/2019
1	NitritesIBA 01/2019
1	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 06/2018
1	Monoamine Oxidase (MAO)IBA 01/2017
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2014
1	efaroxanIBA 10/2013
1	ImidazolinesIBA 10/2013
1	Tamoxifen FDA LinkGeneric 08/2013
1	Hexamethonium (Hexamethonium Bromide)IBA 08/2013
1	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA 07/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2013
1	OligomycinsIBA 01/2013
1	Adenosine Triphosphate (ATP)IBA 01/2013
1	Aminobutyrates (Aminobutyric Acid)IBA 10/2012
1	Type 1 Angiotensin ReceptorIBA 07/2012
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2012
1	Biological ProductsIBA 01/2012
1	Glutathione (Reduced Glutathione)IBA 12/2011
1	Phosphinic Acids (Phosphinic Acid)IBA 09/2011
1	Arginine (L-Arginine)FDA Link 05/2011
1	A 192621IBA 12/2009
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2009
1	Baclofen FDA LinkGeneric 11/2009
1	GABA-B Receptor AgonistsIBA 11/2009
1	NK3201IBA 07/2009

Therapy/Procedure

13	Nephrectomy 01/2014 - 07/2005
3	Intravenous Injections 08/2013 - 11/2009
2	Therapeutics 11/2014 - 05/2005
1	Surgical Instruments (Clip) 01/2022
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 11/2014
1	Ovariectomy (Oophorectomy) 02/2011
1	Ischemic Postconditioning 01/2010